Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients

NCT03030508 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.

NCT NCT03030508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03030508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients
Lead sponsor
Shanghai Changzheng Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
March 31, 2019
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

capecitabine, colorectal cancer